Details for Patent: 8,475,841
✉ Email this page to a colleague
Summary for Patent: 8,475,841
Title: | Controlled release metformin formulations |
Abstract: | Sustained release pharmaceutical formulations comprising an antihyperglycemic drug or a pharmaceutically acceptable salt thereof are disclosed. The formulations provide therapeutic plasma levels of the antihyperglycemic drug to a human patient over a 24 hour period after administration. |
Inventor(s): | Cheng; Xiu Xiu (Weston, FL), Jan; Steve (Coral Spings, FL), Chou; Joseph (Manasses, VA), Chen; Chih-Ming (Taipei, TW) |
Assignee: | Andrx Labs, LLC (Davie, FL) |
Application Number: | 13/052,154 |
Patent Claim Types: see list of patent claims | Use; Composition; Formulation; Dosage form; Device; |
Drugs Protected by US Patent 8,475,841
Applicant | Tradename | Generic Name | Dosage | NDA | Approval Date | TE | Type | RLD | RS | Patent No. | Patent Expiration | Product | Substance | Delist Req. | Patented / Exclusive Use | Submissiondate |
---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
>Applicant | >Tradename | >Generic Name | >Dosage | >NDA | >Approval Date | >TE | >Type | >RLD | >RS | >Patent No. | >Patent Expiration | >Product | >Substance | >Delist Req. | >Patented / Exclusive Use | >Submissiondate |
International Family Members for US Patent 8,475,841
Country | Patent Number | Estimated Expiration | Supplementary Protection Certificate | SPC Country | SPC Expiration |
---|---|---|---|---|---|
Australia | 3101999 | ⤷ Sign Up | |||
Australia | 739226 | ⤷ Sign Up | |||
Canada | 2324493 | ⤷ Sign Up | |||
China | 1158999 | ⤷ Sign Up | |||
China | 1308520 | ⤷ Sign Up | |||
Germany | 69941115 | ⤷ Sign Up | |||
>Country | >Patent Number | >Estimated Expiration | >Supplementary Protection Certificate | >SPC Country | >SPC Expiration |